Glanbia plc new CEO appointment
Siobhán will step down from her position and from the Glanbia Board on 31 December 2023 and will retire from the Group in January 2024. Hugh McGuire, currently Chief Executive Officer of Glanbia Performance Nutrition (GPN), will be appointed CEO of Glanbia plc and join the Glanbia Board as an Executive Director effective 1 January 2024.
Siobhán Talbot, Group Managing Director, Glanbia plc added: “It has been my great privilege to lead Glanbia over the past ten years. I am very proud of how the organisation has evolved, grown and strengthened over this period. It is well positioned for the next phase of growth with great people, culture and capabilities. I want to thank my leadership team and all my colleagues right across the Group for their hard work and commitment to Glanbia and their personal friendship.”
Hugh McGuire, CEO of Glanbia Performance Nutrition added: “I am honoured and delighted to have been appointed as the next CEO of Glanbia, an organisation I have been proud to serve over the last 20 years. It is a business and a sector that is closely aligned to my own passions and values and I’ve been privileged to be part of its transformation journey.”
Financial Results
Glanbia plc announces its half year financial results for the six month period ended 1 July 2023.
As announced on 1 March 2023, the Group has changed its presentation currency from Euro to US Dollar. All figures presented are in US Dollar unless stated otherwise, with comparative figures also restated in US Dollar.
Key highlights from HY 2023:
- Earnings growth in the first half, positive outlook for the remainder of 2023; full year guidance upgraded to between 12% and 15% growth in adjusted EPS reflecting improved outlook for GPN;
- Group revenues of $2.8 billion (HY 2022: $3.1 billion) representing a decrease of 10.0% constant currency (down 10.3% reported);
- Group EBITA pre-exceptional of $198.6 million (HY 2022: $187.6 million), an increase of 6.1% constant currency (up 5.9% reported);
- Group EBITA pre-exceptional margins of 7.2% (HY 2022: 6.1%) with margin growth across all business segments;
- Adjusted earnings per share of 60.78 $cent (HY 2022: 57.17 $cent) representing growth of 6.6% constant currency (up 6.3% reported);
- Basic EPS from continuing operations of 71.90 $cent (HY 2022: 50.40 $cent);
- Glanbia Performance Nutrition (“GPN”):
- Like-for-like (“LFL”) branded revenue +3.7% with pricing +10.9% and volume -7.2%;
- Optimum Nutrition (“ON”) brand delivered LFL revenue growth of +16.2% with volume and price momentum; ON sustained US consumption growth2 of 14.3%;
- EBITA margin 12.1% (HY 2022: 10.4%), an increase of 170bps;
- Glanbia Nutritionals - Nutritional Solutions (“GN NS”):
- LFL revenue -15.2% with pricing -4.8% and volume -10.4%;
- EBITA margin 12.9% (HY 2022: 12.2%), an increase of 70bps;
- Sequential improvement in volumes through the period;
- Capital allocation:
- Interim dividend increased by 10% to 14.22 €cent per share;
- Returned €64.5 million to shareholders in the period via share buyback activity;
- Completed the sale of Glanbia Cheese joint ventures for initial proceeds of €178.9 million (including the repayment of shareholder loans);
- Strong balance sheet with net debt to adjusted EBITDA ratio of 0.99 times (HY 2022: 1.75 times); and
- Siobhán Talbot to retire as Group Managing Director on 31 December 2023, Hugh McGuire to be appointed CEO on 1 January 2024.
- Adjusted Earnings Per Share (“EPS”) growth on a constant currency basis
- Consumption growth is US measured in channels and includes Online, FDMC (Food, Drug, Mass, Club) and Specialty channels. Data compiled from published external sources and Glanbia estimates for the 12 week period to 16 July 2023
Commenting today Siobhán Talbot, Group Managing Director, said:
“I am pleased to report that Glanbia’s performance in the first half of the year was ahead of our expectations as the Group successfully navigated some continuing volatility in global market conditions. This was driven by a strong operating performance, continued demand for our better nutrition brands and ingredients and the exceptional commitment of our people. We are upgrading our guidance for FY 2023, with adjusted Earnings Per Share now expected to grow by between 12% and 15% on a constant currency basis.
Our earnings momentum in the first half of 2023 was driven by a good performance in GPN as growth in revenue, earnings and margin reflected a strong global performance for our flagship Optimum Nutrition brand. GN’s first half performance was in line with expectations, as customer supply chain rebalancing trends reduced volumes, with progressive improvements in demand trends as the period progressed which we expect to continue into the second half of the year.
Our strategy is on track as we continue to reshape and simplify our portfolio, invest to sustain consumer and customer relevance, drive margin improvement and deliver strong operating returns and cash conversion. In terms of returns to shareholders, the interim dividend is raised by 10% and €64.5 million was returned in the period via share buybacks. As we look to the second half of the year, we believe that the combination of market opportunity and our strong operating capabilities set us up for sustained delivery of future growth.”

- This release contains certain alternative performance measures. Detailed explanation of the key performance indicators and non-IFRS performance measures can be found in the glossary on pages 37 to 45.
- There was no profit or loss from discontinued operations in the period. In HY 2022, an exceptional profit after tax from discontinued operations of $61.1m arose, relating to the once-off profit on disposal of the Group’s interest in Tirlán Limited (formerly known as Glanbia Ireland DAC).
- To arrive at the constant currency change, the average exchange rate for the current period is applied to the relevant reported result from the same period in the prior year. The average US dollar euro exchange rate for HY 2023 was $1 = €0.9253 (HY 2022: $1 = €0.9151). Reported and constant currency movements are on a pre-exceptional basis.
- EBITA (pre-exceptional) is defined as earnings before interest, tax and amortisation.
HY 2023 results summary (pre-exceptional)

2023 half year overview
Glanbia delivered a strong financial and operating performance in HY 2023. Group revenue was $2,771.4 million (HY 2022: $3,091.3 million), down 10.0% constant currency (down 10.3% reported). Group EBITA (before exceptional items) was $198.6 million (HY 2022: $187.6 million) up 6.1% constant currency (up 5.9% reported). Group profit after tax from continuing operations for the period was $193.4 million (HY 2022: $140.4 million) up $53.6 million constant currency (up $53.0 million reported).
Adjusted earnings per share (“EPS”) was 60.78 $cent (HY 2022: 57.17 $cent) up 6.6% constant currency (up 6.3% reported).
Balance sheet and financing
Glanbia's net debt at 1 July 2023 was $450.8 million (HY 2022: $675.6 million) which represents a decrease of $224.8 million driven by strong cash generation, the sale of the Group’s interest in the Glanbia Cheese mozzarella joint ventures and a disciplined approach to capital allocation. Net debt to adjusted EBITDA was 0.99 times (HY 2022: 1.75 times). At the end of the period the Group had committed debt facilities of $1.3 billion. Glanbia’s ability to generate cash and its available debt facilities ensure the Group has considerable capacity to finance future investments.
Capital investment
Glanbia’s total investment in capital expenditure (strategic and maintenance) was $36.8 million in the first half of 2023 (HY 2022: $32.0 million). Strategic investment totalled $27.3 million. Key strategic projects include IT investments and new process technologies in GN NS. Total capital expenditure for the year is expected to be $75 to $85 million.
Dividend per share
The Board is recommending an interim dividend of 14.22 €cent per share (HY 2022: 12.93 €cent per share) representing a 10% increase on prior year interim dividend. Glanbia’s overall dividend policy remains unchanged at a target annual dividend payout ratio of between 25% and 35% of adjusted EPS. The interim dividend will be paid on 6 October 2023 to shareholders on the register of members as at 25 August 2023. Irish withholding tax will be deducted at the standard rate where appropriate. The Company’s primary dividend payment currency remains Euro.
First Published 16 August 2023